Consensus Ventas, Inc. Deutsche Boerse AG

Stocks

VEN

US92276F1003

Specialized REITs

Market Closed - Deutsche Boerse AG 02:02:05 2026-09-16 EDT			5-day change	1st Jan Change
76.48 ^EUR	-0.18%		-0.57%	+13.61%

09-15	Ventas, Inc. Announces Appointment of Laurida Sayed as Senior Vice President, Chief Accounting Officer and Controller, Effective on or About October 5, 2026	CI
09-14	Ventas Keeps Quarterly Dividend at $0.52 a Share, Payable Oct. 15 to Shareholders of Record Sept. 30	MT

7f5da6ad0137ac61c1b6dbf.loCboDaOSwRKxBsOqfF7Xi0m6M5-jX-ROCrju0PjV0U.__rajVn3D1QMnl1Y3JckD1sXoKYz2Bypf23OgiHVBCGvw8nVXOYOZX30eA~f4cb3af5291fcc8bd800b104ffa3d4c8

Analysts' recommendations: Ventas, Inc.

09-02	Scotiabank Adjusts Price Target on Ventas to $95 From $93, Maintains Sector Perform Rating	MT
09-02	JPMorgan Adjusts Price Target on Ventas to $104 From $94, Maintains Overweight Rating	MT
09-01	Wells Fargo Adjusts Price Target on Ventas to $104 From $96, Maintains Overweight Rating	MT
08-31	Barclays Adjusts Price Target on Ventas to $102 From $99, Keeps Equalweight Rating	MT
08-14	Ventas Earnings Growth Supported by Strong Senior Housing Trends, RBC Says	MT
08-14	RBC Adjusts Price Target on Ventas to $99 From $98, Maintains Outperform Rating	MT
08-12	Jefferies Adjusts Price Target on Ventas to $102 From $109, Maintains Buy Rating	MT
08-11	BMO Capital Adjusts Price Target on Ventas to $107 From $105, Keeps Outperform Rating	MT
08-05	Argus Research Adjusts Ventas Price Target to $98 From $92	MT
08-04	Citigroup Adjusts Price Target on Ventas to $110 From $100, Maintains Buy Rating	MT
08-03	Evercore ISI Adjusts Price Target on Ventas to $101 From $96, Maintains Outperform Rating	MT
08-03	BMO Capital Adjusts Price Target on Ventas to $105 From $100, Maintains Outperform Rating	MT
07-30	BNP Paribas Adjusts Ventas Price Target to $110 From $93, Maintains Outperform Rating	MT
07-24	Goldman Sachs Adjusts Price Target on Ventas to $114 From $110, Maintains Buy Rating	MT
07-22	Mizuho Adjusts Price Target on Ventas to $104 From $98, Maintains Outperform Rating	MT
07-15	Jefferies Adjusts Price Target on Ventas to $109 From $100, Maintains Buy Rating	MT
07-10	Scotiabank Adjusts Price Target on Ventas to $93 From $88	MT
07-01	Evercore ISI Adjusts Ventas Price Target to $96 From $95, Maintains Outperform Rating	MT
06-18	Scotiabank Adjusts Price Target on Ventas to $88 From $95, Maintains Sector Perform Rating	MT
06-16	Deutsche Bank Lifts Price Target on Ventas to $100 From $95, Keeps Buy Rating	MT
06-01	Wells Fargo Adjusts Price Target on Ventas to $96 From $93, Maintains Overweight Rating	MT
05-26	BofA Adjusts Price Target on Ventas to $110 From $102	MT
05-22	Baird Adjusts Price Target on Ventas to $98 From $97, Maintains Outperform Rating	MT
05-22	Mizuho Adjusts Price Target on Ventas to $98 From $94, Maintains Outperform Rating	MT
05-21	Scotiabank Adjusts Price Target on Ventas to $95 From $93, Maintains Sector Perform Rating	MT

More recommendations

Healthcare REITs

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
VENTAS, INC.	-	-	-	-
WELLTOWER INC.				+12.66%
VENTAS, INC.				+15.02%
OMEGA HEALTHCARE INVESTORS, INC.				+10.1%
HEALTHPEAK PROPERTIES, INC.				+14.09%
AMERICAN HEALTHCARE REIT, INC.				+21.3%
CARETRUST REIT, INC.				+17.53%
HEALTHCARE REALTY TRUST INCORPORATED				+14.83%
AEDIFICA				+25.26%
SABRA HEALTH CARE REIT, INC.				+12.41%
Average				+15.91%
Weighted average by Cap.				+13.85%